The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Keelogane SC 25 mg/ml Oral suspension

25 milligram(s)/millilitre Oral suspension

Bimeda Animal Health LimitedVPA22033/025/001

Main Information

Trade NameKeelogane SC 25 mg/ml Oral suspension
Active SubstancesAlbendazole
Strength25 milligram(s)/millilitre
Dosage FormOral suspension
Licence HolderBimeda Animal Health Limited
Licence NumberVPA22033/025/001

Group Information

ATC CodeQP52AC11 albendazole
Therapeutic ClassEndoparasiticide


Licence Issued30/06/2003
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back